Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis
- PMID: 36761976
- PMCID: PMC9902931
- DOI: 10.3389/fonc.2023.1071770
Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis
Abstract
Introduction: Primary malignant cardiac tumors (PMCTs) are rare. Geographical distribution has been demonstrated to affect cancer outcomes, making the reduction of geographical inequalities a major priority for cancer control agencies. Geographic survival disparities have not been reported previously for PMCT and the aim of this study is to compare the prevalence and the long-term survival rate with respect to the geographic location of PMCTs using the Surveillance, Epidemiology, and End Results (SEER) research plus data 17 registries between 2000 and 2019.
Methods: The SEER database was queried to identify geographic variation among PMCTs. We classified the included states into 4 geographical regions (Midwest, Northeast, South and West regions) based on the U.S. Census Bureau-designated regions and divisions. Different demographic and clinical variables were analyzed and compared between the four groups. Kaplan Meier curves and Cox regression were used for survival assessment.
Results: A total of 563 patients were included in our analysis. The median age was 53 years (inter-quartile range (IQR): 38 - 68 years) and included 26, 90, 101, and 346 patients from the Midwest, Northeast, South, and West regions respectively. Sarcoma represented 65.6% of the cases, followed by hematological tumors (26.2%), while mesothelioma accounted for 2.1%. Treatment analysis showed no significant differences between different regions. Median overall survival was 11, 21, 13, and 11 months for Midwest, Northeast, South and West regions respectively and 5-year overall survival was 22.2%, 25.4%, 14.9%, and 17.6% respectively. On multivariate Cox regression, significant independent predictors of late overall mortality among the entire cohort included age (Hazard Ratio [HR] 1.028), year of diagnosis (HR 0.967), sarcoma (HR 3.36), surgery (HR 0.63) and chemotherapy (HR 0.56).
Conclusion: Primary malignant cardiac tumors are rare and associated with poor prognosis. Sarcoma is the most common pathological type. Younger age, recent era diagnosis, surgical resection, and chemotherapy were the independent predictors of better survival. While univariate analysis revealed that patients in the South areas had a worse survival trend compared to other areas, geographic disparity in survival was nullified in multivariate analysis.
Keywords: cardiac surgery; database analysis; geographic variation; oncology; primary malignant cardiac tumors.
Copyright © 2023 Rahouma, Khairallah, Dabsha, Baudo, El-Sayed Ahmed, Gambardella, Lau, Esmail, Mohamed, Girardi, Gaudino, Lorusso and Mick.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) Database.Cancers (Basel). 2024 Oct 3;16(19):3383. doi: 10.3390/cancers16193383. Cancers (Basel). 2024. PMID: 39410002 Free PMC article.
-
Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients.J Thorac Dis. 2023 Aug 31;15(8):4434-4444. doi: 10.21037/jtd-23-1054. Epub 2023 Aug 25. J Thorac Dis. 2023. PMID: 37691678 Free PMC article.
-
Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors over the Past 2 Decades.Diseases. 2023 May 14;11(2):74. doi: 10.3390/diseases11020074. Diseases. 2023. PMID: 37218887 Free PMC article.
-
Cardiac tumors prevalence and mortality: A systematic review and meta-analysis.Int J Surg. 2020 Apr;76:178-189. doi: 10.1016/j.ijsu.2020.02.039. Epub 2020 Mar 10. Int J Surg. 2020. PMID: 32169566
-
Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.Surg Oncol. 2017 Jun;26(2):117-124. doi: 10.1016/j.suronc.2017.01.008. Epub 2017 Feb 2. Surg Oncol. 2017. PMID: 28577717 Review.
Cited by
-
Reduced Risk of All-Cause, Cancer-, and Cardiovascular Disease-Related Mortality among Patients with Primary Malignant Cardiac Tumors Receiving Chemotherapy in the United States.Curr Oncol. 2023 Sep 15;30(9):8488-8500. doi: 10.3390/curroncol30090618. Curr Oncol. 2023. PMID: 37754533 Free PMC article.
-
Geospatial Patterns of Non-Melanoma Skin Cancer in Relation to Climate Changes in Iran.Asian Pac J Cancer Prev. 2024 Mar 1;25(3):1053-1063. doi: 10.31557/APJCP.2024.25.3.1053. Asian Pac J Cancer Prev. 2024. PMID: 38546088 Free PMC article.
References
-
- Realdo C. De re anatomica. Venice: Nicolae Beuil-acquae [Facsimile Culture et Civilisation, Bruxelles; (1969).
-
- Barnes AR, Beaver DC, Snell AM. Primary sarcoma of the heart: report of a case with electrocardiographic and pathological studies. Am Heart J (1934) 9(4):480–91. doi: 10.1016/S0002-8703(34)90096-X - DOI
LinkOut - more resources
Full Text Sources